NCT01262690 - A Study In Healthy Subjects Of Single Doses of PF-05230901 Injected Under The Skin | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

Cachexia

Interventions

DRUG

PF-05230901

Single ascending doses of PF-05230901 in separate cohorts of subjects; each cohort consists of 6 subjects treated with PF-05230901 and 3 subjects treated with placebo.

DRUG

PF-05230901

Single dose SC

Trial Locations (1)

06511

Pfizer Investigational Site, New Haven